Connection

Bryan Toole to Glioma

This is a "connection" page, showing publications Bryan Toole has written about Glioma.
Connection Strength

0.687
  1. Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas. J Child Neurol. 2008 Oct; 23(10):1214-20.
    View in: PubMed
    Score: 0.279
  2. Perturbation of hyaluronan interactions inhibits malignant properties of glioma cells. Am J Pathol. 2003 May; 162(5):1403-9.
    View in: PubMed
    Score: 0.192
  3. Hyaluronan regulates ceruloplasmin production by gliomas and their treatment-resistant multipotent progenitors. J Child Neurol. 2008 Oct; 23(10):1221-30.
    View in: PubMed
    Score: 0.070
  4. Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multipotent progenitors. Clin Cancer Res. 2008 Mar 15; 14(6):1804-13.
    View in: PubMed
    Score: 0.067
  5. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Int J Cancer. 2000 Oct 01; 88(1):21-7.
    View in: PubMed
    Score: 0.040
  6. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett. 2000 Sep 01; 157(2):177-84.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.